Device group urges FDA to refine software function guidance

The Advanced Medical Technology Association (AdvaMed) urged the US Food and Drug Administration (FDA) to refine its draft guidance on device software in premarket submissions, asserting that requiring enhanced documentation for certain types of devices is problematic; while GE Healthcare called for greater clarity on how FDA determines whether a device should be subject to basic or enhanced levels of documentation.